Global Parkinson's Disease Drug Market Research Report 2021

August 2016 | 102 pages | ID: G2BEF4FD063EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Parkinson's Disease Drug

Revenue, means the sales value of Parkinson's Disease Drug

This report studies Parkinson's Disease Drug in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering

• GlaxoSmithKline
• Novartis
• Teva Pharmaceutical
• Abbvie
• Akorn
• Astellas Pharma
• Desitin Arzneimittel
• Endo International
• Roche
• H. Lundbeck
• Kyowa Hakko Kirin
• Merck
• Orion
• STADA Arzneimittel
• UCB
• US WorldMeds
• Valeant Pharmaceuticals

Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Parkinson's Disease Drug in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• India
• Southeast Asia

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Parkinson's Disease Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Parkinson's Disease Drug Market Research Report 2021

1 PARKINSON'S DISEASE DRUG OVERVIEW

1.1 Product Overview and Scope of Parkinson's Disease Drug
1.2 Parkinson's Disease Drug Segment by Types
  1.2.1 Global Sales Market Share of Parkinson's Disease Drug by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Parkinson's Disease Drug Segment by Applications
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Parkinson's Disease Drug Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Parkinson's Disease Drug (2011-2021)
  1.5.1 Global Parkinson's Disease Drug Sales and Revenue (2011-2021)
  1.5.2 Global Parkinson's Disease Drug Sales and Growth Rate (2011-2021)
  1.5.3 Global Parkinson's Disease Drug Revenue and Growth Rate (2011-2021)

2 GLOBAL PARKINSON'S DISEASE DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Parkinson's Disease Drug Sales and Share by Manufacturers (2015 and 2016)
2.2 Global Parkinson's Disease Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 Manufacturers Parkinson's Disease Drug Manufacturing Base Distribution and Product Type
2.4 Competitive Situation and Trends
  2.4.1 Expansions
  2.4.2 New Product Launches
  2.4.3 Acquisitions
  2.4.4 Other Developments

3 GLOBAL PARKINSON'S DISEASE DRUG ANALYSIS BY REGION

3.1 Global Parkinson's Disease Drug Sales, Revenue and Market Share by Region (2011-2021)
  3.1.1 Global Parkinson's Disease Drug Sales Market Share by Region (2011-2021)
  3.1.2 Global Parkinson's Disease Drug Revenue Market Share by Region (2011-2021)
3.2 North America
  3.2.1 North America Parkinson's Disease Drug Sales, Revenue and Price (2011-2021)
  3.2.2 North America Parkinson's Disease Drug Sales, Revenue and Growth Rate (2011-2021)
3.3 Europe
  3.3.1 Europe Parkinson's Disease Drug Sales, Revenue and Price (2011-2021)
  3.3.2 Europe Parkinson's Disease Drug Sales, Revenue and Growth Rate (2011-2021)
3.4 China
  3.4.1 China Parkinson's Disease Drug Sales, Revenue and Price (2011-2021)
  3.4.2 China Parkinson's Disease Drug Sales, Revenue and Growth Rate (2011-2021)
3.5 Japan
  3.5.1 Japan Parkinson's Disease Drug Sales, Revenue and Price (2011-2021)
  3.5.2 Japan Parkinson's Disease Drug Sales, Revenue and Growth Rate (2011-2021)
3.6 India
  3.6.1 India Parkinson's Disease Drug Sales, Revenue and Price (2011-2021)
  3.6.2 India Parkinson's Disease Drug Sales, Revenue and Growth Rate (2011-2021)
3.7 Southeast Asia
  3.7.1 Southeast Asia Parkinson's Disease Drug Sales, Revenue and Price (2011-2021)
  3.7.2 Southeast Asia Parkinson's Disease Drug Sales, Revenue and Growth Rate (2011-2021)

4 GLOBAL PARKINSON'S DISEASE DRUG ANALYSIS BY TYPE

4.1 Global Parkinson's Disease Drug Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)
  4.1.1 Global Parkinson's Disease Drug Sales and Market Share by Type (2011-2021)
  4.1.2 Global Parkinson's Disease Drug Revenue, Market Share and Growth Rate by Type (2011-2021)
4.2 Type I Sales, Revenue, Price and Growth (2011-2020)
4.3 Type II Sales, Revenue, Price and Growth (2011-2020)
4.4 Type III Sales, Revenue, Price and Growth (2011-2020)

5 GLOBAL PARKINSON'S DISEASE DRUG MARKET ANALYSIS BY APPLICATION

5.1 Global Parkinson's Disease Drug Sales and Market Share by Application (2011-2021)
5.2 Major Regions Parkinson's Disease Drug Sales by Application in 2015 and 2016
  5.2.1 North America Parkinson's Disease Drug Sales by Application
  5.2.2 Europe Parkinson's Disease Drug Sales by Application
  5.2.3 China Parkinson's Disease Drug Sales by Application
  5.2.4 Japan Parkinson's Disease Drug Sales by Application
  5.2.5 India Parkinson's Disease Drug Sales by Application
  5.2.6 Southeast Asia Parkinson's Disease Drug Sales by Application

6 GLOBAL PARKINSON'S DISEASE DRUG MANUFACTURERS ANALYSIS

6.1 GlaxoSmithKline
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Parkinson's Disease Drug Product Overview
    6.1.2.1 Type I
    6.1.2.2 Type II
    6.1.2.3 Type III
  6.1.3 Parkinson's Disease Drug Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
6.2 Novartis
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Parkinson's Disease Drug Product Overview
    6.2.2.1 Type I
    6.2.2.2 Type II
    6.2.2.3 Type III
  6.2.3 Parkinson's Disease Drug Sales, Revenue, Price of Novartis (2015 and 2016)
6.3 Teva Pharmaceutical
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Parkinson's Disease Drug Product Overview
    6.3.2.1 Type I
    6.3.2.2 Type II
    6.3.2.3 Type III
  6.3.3 Parkinson's Disease Drug Sales, Revenue, Price of Teva Pharmaceutical (2015 and 2016)
6.4 Abbvie
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Parkinson's Disease Drug Product Overview
    6.4.2.1 Type I
    6.4.2.2 Type II
  6.4.3 Parkinson's Disease Drug Sales, Revenue, Price of Abbvie (2015 and 2016)
6.5 Akorn
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Parkinson's Disease Drug Product Overview
    6.5.2.1 Type I
    6.5.2.2 Type II
  6.5.3 Parkinson's Disease Drug Sales, Revenue, Price of Akorn (2015 and 2016)
6.6 Astellas Pharma
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Parkinson's Disease Drug Product Overview
    6.6.2.1 Type I
    6.6.2.2 Type II
  6.6.3 Parkinson's Disease Drug Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
6.7 Desitin Arzneimittel
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Parkinson's Disease Drug Product Overview
    6.7.2.1 Type I
    6.7.2.2 Type II
  6.7.3 Parkinson's Disease Drug Sales, Revenue, Price of Desitin Arzneimittel (2015 and 2016)
6.8 Endo International
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Parkinson's Disease Drug Product Overview
    6.8.2.1 Type I
    6.8.2.2 Type II
  6.8.3 Parkinson's Disease Drug Sales, Revenue, Price of Endo International (2015 and 2016)
6.9 Roche
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Parkinson's Disease Drug Product Overview
    6.9.2.1 Type I
    6.9.2.2 Type II
  6.9.3 Parkinson's Disease Drug Sales, Revenue, Price of Roche (2015 and 2016)
6.10 H. Lundbeck
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Parkinson's Disease Drug Product Overview
    6.10.2.1 Type I
    6.10.2.2 Type II
  6.10.3 Parkinson's Disease Drug Sales, Revenue, Price of H. Lundbeck (2015 and 2016)
6.11 Kyowa Hakko Kirin
6.12 Merck
6.13 Orion
6.14 STADA Arzneimittel
6.15 UCB
6.16 US WorldMeds
6.17 Valeant Pharmaceuticals

7 INDUSTRY POLICY ANALYSIS

8 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Parkinson's Disease Drug
Figure Global Sales Market Share of Parkinson's Disease Drug by Type in 2015
Table Parkinson's Disease Drug Product Type of by Manufacturers
Table Parkinson's Disease Drug Sales Market Share by Application in 2015 and 2016
Figure North America Parkinson's Disease Drug Revenue and Growth Rate (2011-2021)
Figure China Parkinson's Disease Drug Revenue and Growth Rate (2011-2021)
Figure Europe Parkinson's Disease Drug Revenue and Growth Rate (2011-2021)
Figure Japan Parkinson's Disease Drug Revenue and Growth Rate (2011-2021)
Figure India Parkinson's Disease Drug Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Parkinson's Disease Drug Revenue and Growth Rate (2011-2021)
Table Global Parkinson's Disease Drug Sales and Revenue (2011-2021)
Figure Global Parkinson's Disease Drug Sales and Growth Rate (2011-2021)
Figure Global Parkinson's Disease Drug Revenue and Growth Rate (2011-2021)
Table Global Parkinson's Disease Drug Sales of Key Manufacturers (2015 and 2016)
Table Global Parkinson's Disease Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Parkinson's Disease Drug Sales Share by Manufacturers
Figure 2016 Parkinson's Disease Drug Sales Share by Manufacturers
Table Global Parkinson's Disease Drug Revenue by Manufacturers (2015 and 2016)
Table Global Parkinson's Disease Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Parkinson's Disease Drug Revenue Share by Manufacturers
Table 2016 Global Parkinson's Disease Drug Revenue Share by Manufacturers
Table Manufacturers Parkinson's Disease Drug Manufacturing Base Distribution and Product Type
Table Global Parkinson's Disease Drug Sales Market by Region (2011-2021)
Figure Global Parkinson's Disease Drug Sales Market by Region (2011-2021)
Figure Global Parkinson's Disease Drug Sales Market Share by Region (2011-2021)
Table Global Parkinson's Disease Drug Revenue Market by Region (2011-2021)
Table Global Parkinson's Disease Drug Revenue Market Share by Region (2011-2021)
Table North America Parkinson's Disease Drug Sales, Revenue and Price (2011-2021)
Figure North America Parkinson's Disease Drug Sales, Revenue and Growth Rate (2011-2021)
Table Europe Parkinson's Disease Drug Sales, Revenue and Price (2011-2021)
Figure Europe Parkinson's Disease Drug Sales, Revenue and Growth Rate (2011-2021)
Table China Parkinson's Disease Drug Sales, Revenue and Price (2011-2021)
Figure China Parkinson's Disease Drug Sales, Revenue and Growth Rate (2011-2021)
Table Japan Parkinson's Disease Drug Sales, Revenue and Price (2011-2021)
Figure Japan Parkinson's Disease Drug Sales, Revenue and Growth Rate (2011-2021)
Table India Parkinson's Disease Drug Sales, Revenue and Price (2011-2021)
Figure India Parkinson's Disease Drug Sales, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Parkinson's Disease Drug Sales, Revenue and Price (2011-2021)
Figure Southeast Asia Parkinson's Disease Drug Sales, Revenue and Growth Rate (2011-2021)
Table Global Parkinson's Disease Drug Sales by Type (2011-2021)
Table Global Parkinson's Disease Drug Sales Share by Type (2011-2021)
Figure Sales Market Share of Parkinson's Disease Drug by Type (2011-2021)
Figure Global Parkinson's Disease Drug Sales Growth Rate by Type (2011-2021)
Table Global Parkinson's Disease Drug Revenue by Type (2011-2021)
Table Global Parkinson's Disease Drug Revenue Share by Type (2011-2021)
Figure Global Parkinson's Disease Drug Revenue Growth Rate by Type (2011-2021)
Figure Type I Sales, Revenue and Growth (2011-2021)
Figure Type I Price Trend (2011-2021)
Figure Type II Sales, Revenue and Growth (2011-2021)
Figure Type II Price Trend (2011-2021)
Figure Type III Sales, Revenue and Growth (2011-2021)
Figure Type III Price Trend (2011-2021)
Table Global Parkinson's Disease Drug Sales by Application (2011-2021)
Table Global Parkinson's Disease Drug Sales Market Share by Application (2011-2021)
Figure Global Parkinson's Disease Drug Sales Market Share by Application in 2015
Figure Global Parkinson's Disease Drug Sales Market Share by Application in 2021
Table North America Parkinson's Disease Drug Sales by Application (2015 and 2016)
Table Europe Parkinson's Disease Drug Sales by Application (2015 and 2016)
Table China Parkinson's Disease Drug Sales by Application (2015 and 2016)
Table Japan Parkinson's Disease Drug Sales by Application (2015 and 2016)
Table India Parkinson's Disease Drug Sales by Application (2015 and 2016)
Table Southeast Asia Parkinson's Disease Drug Sales by Application (2015 and 2016)
Table Global Parkinson's Disease Drug Sales Growth Rate by Application (2011-2021)
Figure Global Parkinson's Disease Drug Sales Growth Rate by Application (2011-2021)
Table GlaxoSmithKline Basic Information List
Table Parkinson's Disease Drug Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Novartis Basic Information List
Table Parkinson's Disease Drug Sales, Revenue, Price of Novartis (2015 and 2016)
Table Teva Pharmaceutical Basic Information List
Table Parkinson's Disease Drug Sales, Revenue, Price of Teva Pharmaceutical (2015 and 2016)
Table Abbvie Basic Information List
Table Parkinson's Disease Drug Sales, Revenue, Price of Abbvie (2015 and 2016)
Table Akorn Basic Information List
Table Parkinson's Disease Drug Sales, Revenue, Price of Akorn (2015 and 2016)
Table Astellas Pharma Basic Information List
Table Parkinson's Disease Drug Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
Table Desitin Arzneimittel Basic Information List
Table Parkinson's Disease Drug Sales, Revenue, Price of Desitin Arzneimittel (2015 and 2016)
Table Endo International Basic Information List
Table Parkinson's Disease Drug Sales, Revenue, Price of Endo International (2015 and 2016)
Table Roche Basic Information List
Table Parkinson's Disease Drug Sales, Revenue, Price of Roche (2015 and 2016)
Table H. Lundbeck Basic Information List
Table Parkinson's Disease Drug Sales, Revenue, Price of H. Lundbeck (2015 and 2016)
Table Kyowa Hakko Kirin Basic Information List
Table Parkinson's Disease Drug Sales, Revenue, Price of Kyowa Hakko Kirin (2015 and 2016)
Table Merck Basic Information List
Table Parkinson's Disease Drug Sales, Revenue, Price of Merck (2015 and 2016)
Table Orion Basic Information List
Table Parkinson's Disease Drug Sales, Revenue, Price of Orion (2015 and 2016)
Table STADA Arzneimittel Basic Information List
Table Parkinson's Disease Drug Sales, Revenue, Price of STADA Arzneimittel (2015 and 2016)
Table UCB Basic Information List
Table Parkinson's Disease Drug Sales, Revenue, Price of UCB (2015 and 2016)
Table US WorldMeds Basic Information List
Table Parkinson's Disease Drug Sales, Revenue, Price of US WorldMeds (2015 and 2016)
Table Valeant Pharmaceuticals Basic Information List
Table Parkinson's Disease Drug Sales, Revenue, Price of Valeant Pharmaceuticals (2015 and 2016)